PNH - paroxysmal nocturnal hemoglobinuria

Clinical trials for PNH - paroxysmal nocturnal hemoglobinuria explained in plain language.

Never miss a new study

Get alerted when new PNH - paroxysmal nocturnal hemoglobinuria trials appear

Sign up with your email to follow new studies for PNH - paroxysmal nocturnal hemoglobinuria, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1

New hope for rare blood disorder: experimental antibody EA5 enters human testing

Disease control Recruiting now

This early-stage trial tests the safety of a new drug called EA5 in 24 adults with paroxysmal nocturnal hemoglobinuria (PNH), a rare blood disorder that destroys red blood cells. The drug is an antibody designed to block part of the immune system that attacks blood cells. The goa…

Matched conditions: PNH - PAROXYSMAL NOCTURNAL HEMOGLOBINURIA

Phase 1 • Sponsor: Shanghai Lanyi Therapeutics Co., Ltd. • Aim: Disease control

Last updated Jun 27, 2026 12:34 UTC

PNH - paroxysmal nocturnal hemoglobinuria

Get alerted when new PNH - paroxysmal nocturnal hemoglobinuria trials appear

New hope for rare blood disorder: experimental antibody EA5 enters human testing